New combo therapy shows promise for Hard-to-Treat breast cancer
NCT ID NCT03328026
First seen Apr 01, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This study tested a new treatment combination (SV-BR-1-GM plus retifanlimab) in 36 people with advanced breast cancer that had stopped responding to standard therapies. The goal was to see if the combination is safe and can shrink tumors. Participants received the treatment every three weeks, and the study looked at side effects and tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Center of Kansas (CCK)
Wichita, Kansas, 67214, United States
-
Carle Cancer Institute
Urbana, Illinois, 61801, United States
-
Hematology-Oncology Associates of Fredericksburg, Inc
Fredericksburg, Virginia, 22408, United States
-
Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92663, United States
-
Manhattan Hematology Oncology Associates (MHOA)
Manhattan, New York, 10016, United States
-
Mary Crowley Cancer Research
Dallas, Texas, 75230, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
Nebraska Cancer Specialists
Omaha, Nebraska, 68130, United States
-
Overlook Medical Center Oncology Research, Atlantic Health System
Summit, New Jersey, 07901, United States
-
St Vincent-Frontier Cancer Center
Billings, Montana, 59102, United States
-
St. Joseph Heritage Healthcare
Santa Rosa, California, 95403, United States
-
The Center for Cancer and Blood Disorders a division of American Oncology Partners MD
Bethesda, Maryland, 20817, United States
-
Tranquil Clinical Research
Webster, Texas, 77598, United States
-
University of Miami/Sylvester at Plantation
Plantation, Florida, 33324, United States
Conditions
Explore the condition pages connected to this study.